Deep Neural Networks for Enhancing Nanoparticle Drug Release Kinetics

machine learning

The optimization of drug release kinetics from nanoparticles is crucial for the success of nanomedicine, particularly in precision-targeted therapies for infectious diseases, cancer, and chronic inflammatory conditions. The release profiles of nanoparticle-based drug delivery systems significantly influence therapeutic efficacy, systemic toxicity, and patient compliance. Traditional methods for tuning release profiles are often resource-intensive and fail to capture the complexity of the underlying factors. Recently, deep neural networks (DNNs) have emerged as powerful tools for modeling drug release kinetics by leveraging large experimental datasets to capture nonlinear relationships between variables such as polymer composition, particle size, drug loading, pH sensitivity, and more. DNNs provide predictive insights into drug release behaviour, even in cases where mechanistic understanding is incomplete. These models can be used to inversely predict optimal nanoparticle design parameters for achieving desired release profiles, thus accelerating the development of nanoparticle-based therapies. By combining DNNs with mechanistic models, hybrid frameworks are created that offer enhanced predictive accuracy and regulatory acceptance. Furthermore, advances in high-throughput screening and explainable AI techniques enable the generation of high-quality datasets and provide insights into the factors driving drug release. This integrated approach has the potential to streamline the design process for nanoparticle drug delivery systems, enhancing their efficacy and minimizing experimental costs.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.